Search For "dcgi"
Covaxin for Children will take some more time for final approval: Sources
Updated : 4 years, 4 months ago IST
New Delhi [India], November 8 (ANI): The data for Bharat Biotech's Covaxin for Children, COVID-19 vaccine, is under evaluation and the process will take some more time for final approval from the Drugs Controller General of India (DCGI), sources said.
Read More
We are waiting for DCGI approval for children's COVID-19 vaccine: Bharat B
Updated : 4 years, 4 months ago IST
New Delhi [India], October 23(ANI): Chairman and Managing Director of Bharat Biotech, Dr. Krishna Ella on Saturday said that they are waiting for approval from the Drugs Controller General of India (DCGI) for the COVID-19 vaccine for children.
Read More
As India reaches 100 crore vaccinations, a look at its basket of COVID-19
Updated : 4 years, 4 months ago IST
New Delhi [India], October 21 (ANI): As India achieved the milestone of vaccinating over 100 crore citizens on Thursday, we take look at the basket of vaccines developed, manufactured or in use in the country.
Read More
Awaiting regulatory approval for rolling out Covaxin for children aged 2-1
Updated : 4 years, 5 months ago IST
New Delhi [India], October 12 (ANI): The Subject Expert Committee (SEC) has given a recommendation to the Drugs Controller General of India (DCGI) for the use of Bharat Biotech's COVID-19 vaccine, Covaxin, for the beneficiaries aged between 2-18 years, the official sources said on Tuesday
Read More
Approval to Covaxin for children aged between 2-18 years awaited after eva
Updated : 4 years, 5 months ago IST
New Delhi [India], October 12 (ANI): After the evaluation of data Covaxin is yet to get approval by the Drugs Controller General of India (DCGI) for children between 2-18 years old, according to official sources.
Read More
COVID-19: Subject Expert Committee gave recommendation to DCGI to use Cova
Updated : 4 years, 5 months ago IST
New Delhi [India], October 12 (ANI): Subject Expert Committee (SEC) has given a recommendation to the Drugs Controller General of India (DCGI) for the use of Bharat Biotech's COVID-19 vaccine Covaxin for the beneficiaries aged between 2-18 years, the official sources said.
Read More
Priority will be children with comorbidities in paediatric COVID vaccine d
Updated : 4 years, 5 months ago IST
New Delhi [India], October 3 (ANI): Once the COVID-19 vaccination drive for children commences in India, priority would be given to children with comorbidities however severe, said National Immunization Technical Advisory Group (NTAGI) Chairperson Dr NK Arora.
Read More
Sputnik Light Covid vaccine gets permission for Phase 3 trials in India
Updated : 4 years, 6 months ago IST
New Delhi [India], September 15 (ANI): The Drug Controller General of India has given its approval to the single-dose COVID-19 vaccine version of the Sputnik V vaccine 'Sputnik Light' to conduct trials on the Indian population to check whether the vaccine gives a similar immune response i
Read More
DCGI approves Hetero's Tocilizumab for treatment of COVID-19 in hospitalis
Updated : 4 years, 6 months ago IST
Hyderabad (Telangana) [India], September 6 (ANI): Hetero announced on Monday that the Drug Controller General of India (DCGI) has approved Emergency Use Authorization (EUA) for its generic version of Tocilizumab in India for the treatment of COVID-19 in hospitalised adults.
Read More
Biological E gets drug regulator's approval to conduct phase 2/3 trials on
Updated : 4 years, 6 months ago IST
New Delhi [India], September 2 (ANI): The Drug Controller General of India (DCGI) on Wednesday granted permission to Hyderabad-based Biological E Limited to conduct Phase 2 & 3 clinical trials for its anti-COVID shots called Corbevax on children between 5 and 18 years of age with certain
Read More
Wait for two-three months till children get vaccinated against COVID-19, s
Updated : 4 years, 6 months ago IST
New Delhi [India], August 29 (ANI): Stating that India approved Zydus Cadila's DNA vaccine for emergency use in adults and children, Medanta Chairman and Managing Director Dr Naresh Trehan on Sunday cautioned against the re-opening of schools and said that since the vaccine is around the
Read More
Enzene Biosciences Ltd. obtains a Marketing Authorization for its Denosuma
Updated : 4 years, 6 months ago IST
Pune (Maharashtra) [India], August 27 (ANI/PRNewswire): Enzene Biosciences Ltd. "Enzene" announces a successful Marketing Authorization (MA) from the Drug Controller General of India (DCGI) for its third biosimilar drug 'Denosumab', indicated for the treatment of osteoporosis in adults.
Read More